Vimarsana
Biggest News Aggregation in the World

Cell Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Pharma Today - Breaking & Trending Today

Global and Country Cell Therapies for Type 1 Diabetes Research Report 2023: Epidemiology, Pipeline and Target Market Assessment Analysis and Forecast to 2030 - Vimarsana News

Global and Country Cell Therapies for Type 1 Diabetes Research Report 2023: Epidemiology, Pipeline and Target Market Assessment Analysis and Forecast to 2030

Published: November 23, 2023

/PRNewswire/ -- The "Cell Therapies for Type I Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment"...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomSaudi ArabiaLaura WoodS Evans Biosciences Co LtdDiavacs IncCelltrans IncNovo NordiskVertex PharmaceuticalsMesoblast IncThrone Biotechnologies IncAvotres IncE St Office Hours CallOffice Hours CallTypei DiabetesCountry Analysis By EpidemiologyTarget MarketTopics CoveredCell TherapiesTypei Diabetes ComparativeCell EducatorCell PharmaMarket OpportunityFree CallHours Call
NextCell's publication of the phase I/II clinical trial in type I diabetes accepted - Vimarsana News

NextCell's publication of the phase I/II clinical trial in type I diabetes accepted

Published: March 28, 2023

NextCell Pharma AB have had their article detailing the results of their phase I/II clinical trial in type I diabetes accepted in the peer-reviewed journal Diabetologia. NextCell Pharma AB is a... | March 28, 2023

Source: marketscreener.com
Related Topics:
Uppsala LanPatrik FagerholmMathias SvahnOla CarlssonNextcell PharmaSwedish HealthUppsala UniversityKarolinska University HospitalKarolinska Trial AllianceNextcell Pharma Ab Or CompanyPer Ola CarlssonPrincipal InvestigatorTrial AllianceUniversity HospitalCell PharmaCertified AdviserSocial Care InspectorateNextcell Pharma Ab Stock ExchangePress ReleaseS Nxtcl Se0009723125